MARSILID 50 mg, scored tablet 30 tablets
Active ingredients: Iproniazid, Iproniazid phosphate
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Scored tablet30 tabletsorale
Out of stock
Package details
Original BDPM fields are shown in French.
- Official name
- MARSILID 50 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- tube(s) polypropylène de 30 comprimé(s)
- Marketing authorisation holder
- EFISCIENS (MALTE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Sept 2005
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61561635CIP73688250CIP133400936882508Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHOSPHATE D'IPRONIAZIDEcomprimé | 77,42 mg · un comprimé | SA |
| IPRONIAZIDE BASEcomprimé | 50,00 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.